[HTML][HTML] A placebo-controlled trial of bezafibrate in primary biliary cholangitis

C Corpechot, O Chazouillères… - … England Journal of …, 2018 - Mass Medical Soc
Background Patients with primary biliary cholangitis who have an inadequate response to
therapy with ursodeoxycholic acid are at high risk for disease progression. Fibrates, which …

[HTML][HTML] Choledochoscopy: an update

T Lee, TZJ Teng, VG Shelat - World Journal of Gastrointestinal …, 2021 - ncbi.nlm.nih.gov
Choledochoscopy, or cholangioscopy, is an endoscopic procedure for direct visualization
within the biliary tract for diagnostic or therapeutic purposes. Since its conception in 1879 …

Portal vein thrombosis: A concise review

RS Costache, AS Dragomirică… - Experimental and …, 2021 - spandidos-publications.com
Portal vein thrombosis (PVT) is a frequent complication in cirrhotic patients, but it may also
exist as a basic vascular condition even without any liver damage. Local and systemic …

Navigating the liver landscape: upcoming pharmacotherapies for primary sclerosing cholangitis

HN Pham, L Pham, K Sato - Expert Opinion on Pharmacotherapy, 2024 - Taylor & Francis
Introduction Primary sclerosing cholangitis (PSC) is a bile duct disorder characterized by
ductular reaction, hepatic inflammation, and liver fibrosis. The pathogenesis of PSC is still …

Genetic Loss of HIF-Prolyl-Hydroxylase 1, but Not Pharmacological Inhibition, Mitigates Hepatic Fibrosis

C Tuffs, M Dupovac, K Richter, S Holten… - The American Journal of …, 2024 - Elsevier
Liver fibrosis is characterized by excessive deposition of extracellular matrix due to chronic
inflammation of the liver. Hepatic stellate cells (HSCs) become activated and produce …

Suppression of systemic inflammation and signs of acute and chronic cholangitis by multi-kinase inhibitor 1-(4-Cl-benzyl)-3-chloro-4-(CF3-phenylamino)-1H-pyrrole-2 …

H Kuznietsova, I Byelinska, N Dziubenko… - Molecular and Cellular …, 2021 - Springer
An aberrant activity of growth factor receptors followed by excessive cell proliferation plays a
significant role in pathogenesis of cholangitis. Therefore, inhibition of these processes could …

[HTML][HTML] Livogrit Mitigates ANIT-Induced Cholestasis-Like Symptoms in an In Vivo model by Curbing Hepatic Inflammation and Regulating BAX, TGF-β, MMP-9 and α …

A Balkrishna, R Paliwal, S Singh, R Singh, V Gohel… - Heliyon, 2025 - cell.com
Bile duct constriction disrupts bile acid flow causing cholestasis causing hepatic necrosis,
fibrosis, and cirrhosis. The study investigated hepatoprotective effectiveness of Ayurvedic …

Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting

DE Bosch, Y Zen, SA Boukhar, Y Liu, L Cheng… - Virchows Archiv, 2021 - Springer
Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) are biliary tract
pathologies with increased risk of HCC, although HCC is more commonly associated with …

Cholestatic liver disease: Practice guidelines from the Saudi Association for the Study of Liver diseases and Transplantation

M Mawardi, A Alalwan, H Fallatah… - Saudi Journal of …, 2021 - journals.lww.com
Cholestatic liver diseases (CLDs) are a group of diseases characterized by jaundice and
cholestasis as the main presentation with different complications, which have considerable …

Management of autoimmune liver diseases after liver transplantation

R Barba Bernal, E Medina-Morales, D Goyes… - Transplantology, 2021 - mdpi.com
Autoimmune liver diseases are characterized by immune-mediated inflammation and
eventual destruction of the hepatocytes and the biliary epithelial cells. They can progress to …